COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics).

Chary, Michael; Barbuto, Alexander F; Izadmehr, Sudeh; Tarsillo, Marc; Fleischer, Eduardo; Burns, Michele M

Chary, Michael; Barbuto, Alexander F; Izadmehr, Sudeh; Tarsillo, Marc; Fleischer, Eduardo; Burns, Michele M.

Afiliação

Chary M; Division of Medical Toxicology, Department of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA. mic9189@med.cornell.edu.
Barbuto AF; Regional Center for Poison Control and Prevention Serving Massachusetts and Rhode Island, Boston, MA, USA. mic9189@med.cornell.edu.
Izadmehr S; Department of Emergency Medicine, Weill Cornell Medical College, New York, NY, USA. mic9189@med.cornell.edu.
Tarsillo M; Department of Emergency Medicine, New York Presbyterian Queens, Flushing, NY, New York, USA. mic9189@med.cornell.edu.
Fleischer E; Division of Medical Toxicology, Department of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.
Burns MM; Regional Center for Poison Control and Prevention Serving Massachusetts and Rhode Island, Boston, MA, USA.

J Med Toxicol ; 19(2): 205-218, 2023 04.

Article em En | MEDLINE | ID: mdl-36862334

Assuntos

Anticorpos Monoclonais; Soroterapia para COVID-19; COVID-19; Imunoterapia; Vacinas; Feminino; Humanos; Masculino; Anticorpos Monoclonais/uso terapêutico; COVID-19/terapia; Pandemias/prevenção & controle; SARS-CoV-2

Palavras-chave

Covid-19; Immunotherapy; Monoclonal antibodies; Vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 / Soroterapia para COVID-19 / Imunoterapia / Anticorpos Monoclonais Limite: Female / Humans / Male Idioma: En Revista: J Med Toxicol Assunto da revista: TOXICOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google